Researchers test safety of HIV drugs with Gender-Affirming hormones
NCT ID NCT06005610
Summary
This study looked at whether common HIV medications work correctly when taken at the same time as feminizing hormone therapy (estradiol). It involved 93 transgender women living with HIV who were already on stable HIV treatment. Participants received study-provided hormone therapy for 48 weeks while researchers measured drug levels in their blood to check for interactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV I INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Barranco CRS (11301)
Lima, 4, Peru
-
Case CRS (2501)
Cleveland, Ohio, 44106, United States
-
Chapel Hill CRS (3201)
Chapel Hill, North Carolina, 27599-7215, United States
-
Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS (31784)
Chiang Mai, 50200, Thailand
-
Greensboro CRS (3203)
Greensboro, North Carolina, 27401, United States
-
Houston AIDS Research Team CRS (31473)
Houston, Texas, 77030, United States
-
Johns Hopkins University CRS (201)
Baltimore, Maryland, 21205, United States
-
New Jersey Medical School Clinical Research Center CRS (31786)
Newark, New Jersey, 07103, United States
-
Nutrición-Mexico CRS (32078)
Mexico City, Tlalpan, 14080, Mexico
-
Thai Red Cross AIDS Research Centre (TRC-ARC) CRS (31802)
Bangkok, Patumwan, 10330, Thailand
-
The Ponce de Leon Center CRS (5802)
Atlanta, Georgia, 30308, United States
-
UCSD Antiviral Research Center CRS (701)
San Diego, California, 92103, United States
-
University of California, San Francisco HIV/AIDS CRS (801)
San Francisco, California, 94110, United States
-
University of Colorado Hospital CRS (6101)
Aurora, Colorado, 80045, United States
-
Vanderbilt Therapeutics CRS
Nashville, Tennessee, 37204, United States
-
Washington University Therapeutics (WT) CRS (2101)
St Louis, Missouri, 63110-1010, United States
-
Weill Cornell Uptown CRS (site 7803)
New York, New York, 10065, United States
-
Whitman-Walker Institute, Inc. CRS (31791)
Washington D.C., District of Columbia, 20005, United States
Conditions
Explore the condition pages connected to this study.